Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect

References

• Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. (2009). Interleukin 8 and cardiovascular disease. Cardiovasc Res 84:353–60
   PubMed Web of Science ®Google Scholar
• Arnson Y, Shoenfeld Y, Amital H. (2010). Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258–65
   PubMed Web of Science ®Google Scholar
• Barrow SE, Ward PS, Sleightholm MA, et al. (1989). Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Biochim Biophys Acta 993:121–7
   PubMed Web of Science ®Google Scholar
• Bazzano LA, He J, Muntner P, et al. (2003). Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 138:891–7
   PubMed Web of Science ®Google Scholar
• Blann A, Bignell A, McCollum C. (1998). von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis 139:317–22
   PubMed Web of Science ®Google Scholar
• Bolinder G, Alfredsson L, Englund A, de Faire U. (1994). Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 84:399–404
   PubMed Web of Science ®Google Scholar
• Campbell LR, Brown BG, Jones BA, Marano KM, Borgerding MF. (2015). Study of cardiovascular disease biomarkers among tobacco consumers, Part 1: Biomarkers of exposure. Inhal Toxicol (in press)
   Google Scholar
• Calapai G, Caputi AP, Mannucci C, et al. (2009a). A cross-sectional investigation of biomarkers of risk after a decade of smoking. Inhal Toxicol 21:1138–43
   PubMed Web of Science ®Google Scholar
• Calapai G, Caputi AP, Mannucci C, et al. (2009b). Cardiovascular biomarkers in groups of established smokers after a decade of smoking. Basic Clin Pharmacol Toxicol 104:322–8
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Georgakopoulos D, et al. (1993). Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149–55
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2011) National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm [last accessed: 12 Oct 2012]
   Google Scholar
• Ciftci O, Gullu H, Caliskan M, et al. (2009). Mentholated cigarette smoking and brachial artery, carotid artery, and aortic vascular function. Turk Kardiyol Dern Ars 37:234–40
   PubMedGoogle Scholar
• Craig WY, Palomaki GE, Haddow JE. (1989). Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298:784–8
   PubMed Web of Science ®Google Scholar
• de Maat MP, Kluft C. (2002). The association between inflammation markers, coronary artery disease and smoking. Vascul Pharmacol 39:137–9
   PubMedGoogle Scholar
• Eliasson M, Asplund K, Evrin PE, Lundblad D. (1995). Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 113:41–53
   PubMed Web of Science ®Google Scholar
• Eliasson M, Lundblad D, Hagg E. (1991). Cardiovascular risk factors in young snuff-users and cigarette smokers. J Intern Med 230:17–22
   PubMed Web of Science ®Google Scholar
• Esen AM, Barutcu I, Acar M, et al. (2004). Effect of smoking on endothelial function and wall thickness of brachial artery. Circ J 68:1123–6
   PubMed Web of Science ®Google Scholar
• Frost-Pineda K, Liang Q, Liu J, et al. (2011). Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 13:182–93
   PubMed Web of Science ®Google Scholar
• Gee K, Guzzo C, Che Mat NF, et al. (2009). The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8:40–52
   PubMedGoogle Scholar
• Giunzioni I, Bonomo A, Bishop E, et al. (2014). Cigarette smoke condensate affects monocyte interaction with endothelium. Atherosclerosis 234:383–90
   PubMedGoogle Scholar
• Granberry MC, Smith ES III, Troillett RD, Eidt JF. (2003). Forearm endothelial response in smokeless tobacco users compared with cigarette smokers and nonusers of tobacco. Pharmacotherapy 23:974–8
   PubMed Web of Science ®Google Scholar
• Haverslag R, Pasterkamp G, Hoefer IE. (2008). Targeting adhesion molecules in cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 8:252–60
   PubMedGoogle Scholar
• Heffernan KS, Karas RH, Patvardhan EA, Kuvin JT. (2010). Endothelium-dependent vasodilation is associated with exercise capacity in smokers and non-smokers. Vasc Med 15:119–25
   PubMedGoogle Scholar
• Hergens MP, Ahlbom A, Andersson T, Pershagen G. (2005). Swedish moist snuff and myocardial infarction among men. Epidemiology 16:12–6
   PubMed Web of Science ®Google Scholar
• Hidaka T, Hata T, Soga J, et al. (2010). Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers. Hypertens Res 33:354–9
   PubMed Web of Science ®Google Scholar
• Huhtasaari F, Asplund K, Lundberg V, et al. (1992). Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 305:1252–6
   PubMed Web of Science ®Google Scholar
• Jilma B, Dirnberger E, Löscher I, et al. (1997). Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 130:69–75
   PubMedGoogle Scholar
• Kannel WB, D’Agostino RB, Belanger AJ. (1987). Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 113:1006–10
   PubMed Web of Science ®Google Scholar
• Karatzi K, Papamichael C, Karatzis E, et al. (2007a). Acute smoke-induced endothelial dysfunction is more prolonged in smokers than in non-smokers. Int J Cardiol 120:404–6
   PubMed Web of Science ®Google Scholar
• Karatzi K, Papamichael C, Karatzis E, et al. (2007b). Acute smoking induces endothelial dysfunction in healthy smokers. Is this reversible by red wine’s antioxidant constituents? J Am Coll Nutr 26:10–5
   Google Scholar
• Levitzky YS, Guo CY, Rong J, et al. (2008). Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis 201:217–24
   PubMed Web of Science ®Google Scholar
• Liu G, Place AT, Chen Z, et al. (2012). ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration. Blood 120:1942–52
   PubMedGoogle Scholar
• Lowe FJ, Gregg EO, McEwan M. (2009). Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clin Chem Lab Med 47:311–20
   PubMed Web of Science ®Google Scholar
• Mannucci PM. (1998). von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 18:1359–62
   PubMed Web of Science ®Google Scholar
• Marano KM, Kathman SJ, Jones BA, Nordskog BK, Brown BG, Borgerding MF. (2015). Study of cardiovascular disease biomarkers among tobacco consumers, Part 3: Evaluation and comparison with the US National Health and Nutrition Examination Survey. Inhal Toxicol (in press)
   Google Scholar
• Morrow JD, Hill KE, Burk RF, et al. (1990). A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383–7
   PubMed Web of Science ®Google Scholar
• Neunteufl T, Heher S, Kostner K, et al. (2002). Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 39:251–6
   PubMed Web of Science ®Google Scholar
• Nguyen QM, Srinivasan SR, Xu JH, et al. (2010). Distribution and cardiovascular risk correlates of plasma soluble intercellular adhesion molecule-1 levels in asymptomatic young adults from a biracial community: the Bogalusa Heart Study. Ann Epidemiol 20:53–9
   PubMedGoogle Scholar
• Norberg M, Stenlund H, Lindahl B, et al. (2006). Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep’s clothing? Scand J Public Health 34:576–83
   PubMed Web of Science ®Google Scholar
• O’Callaghan PA, Fitzgerald A, Fogarty J, et al. (2005). New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. Eur J Cardiovasc Prev Rehabil 12:542–7
   PubMedGoogle Scholar
• Ozaki K, Hori T, Ishibashi T, et al. (2010). Effects of chronic cigarette smoking on endothelial function in young men. J Cardiol 56:307–13
   PubMedGoogle Scholar
• Papamichael CM, Aznaouridis KA, Stamatelopoulos KS, et al. (2004). Endothelial dysfunction and type of cigarette smoked: the impact of ‘light’ versus regular cigarette smoking. Vasc Med 9:103–5
   PubMed Web of Science ®Google Scholar
• Petrescu F, Voican SC, Silosi I. (2010). Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis 5:217–22
   PubMedGoogle Scholar
• Piano MR, Benowitz NL, Fitzgerald GA, et al. (2010). Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 122:1520–44
   PubMed Web of Science ®Google Scholar
• Poredos P, Orehek M, Tratnik E. (1999). Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology 50:201–8
   PubMed Web of Science ®Google Scholar
• Redberg RF, Vogel RA, Criqui MH, et al. (2003). 34th Bethesda Conference: task force #3–what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J Am Coll Cardiol 41:1886–98
   PubMedGoogle Scholar
• Reilly M, Delanty N, Lawson JA, Fitzgerald GA. (1996). Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19–25
   PubMed Web of Science ®Google Scholar
• Roethig HJ, Feng S, Liang Q, et al. (2008). A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J Clin Pharmacol 48:580–91
   PubMed Web of Science ®Google Scholar
• Roethig HJ, Koval T, Muhammad-Kah R, et al. (2010). Short term effects of reduced exposure to cigarette smoke on white blood cells, platelets and red blood cells in adult cigarette smokers. Regul Toxicol Pharmacol 57:333–7
   PubMed Web of Science ®Google Scholar
• Rohani M, Agewall S. (2004). Oral snuff impairs endothelial function in healthy snuff users. J Intern Med 255:379–83
   PubMed Web of Science ®Google Scholar
• Rokach J, Khanapure SP, Hwang SW, et al. (1997). The isoprostanes: a perspective. Prostaglandins 54:823–51
   PubMedGoogle Scholar
• Rush University Medical Center. (2011). Rush Medical Laboratory user’s guide. Chicago, IL: Rush University Medical Center. Available from: http://rml.rush.edu/webapps/rml/RMLRanges.jsp
   Google Scholar
• Sanderson KJ, van Rij AM, Wade CR, Sutherland WH. (1995). Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 118:45–51
   PubMed Web of Science ®Google Scholar
• Siasos G, Tousoulis D, Vlachopoulos C, et al. (2008). Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals. Int J Cardiol 126:394–9
   PubMed Web of Science ®Google Scholar
• Siasos G, Tousoulis D, Vlachopoulos C, et al. (2009). The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. Am J Hypertens 22:586–92
   PubMed Web of Science ®Google Scholar
• Siegel D, Benowitz N, Ernster VL, et al. (1992). Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health 82:417–21
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Hirsch AT, Haskal ZJ, et al. ACC/AHA. (2005). Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113:e463–654
   Google Scholar
• Takeuchi N, Kawamura T, Kanai A, et al. (2002). The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with type 2 diabetes mellitus. Diabet Med 19:57–64
   PubMed Web of Science ®Google Scholar
• Thorne S, Mullen MJ, Clarkson P, et al. (1998). Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 32:110–6
   PubMed Web of Science ®Google Scholar
• Tucker LA. (1989). Use of smokeless tobacco, cigarette smoking, and hypercholesterolemia. Am J Public Health 79:1048–50
   PubMed Web of Science ®Google Scholar
• Unverdorben M, von Holt K, Winkelmann BR. (2009). Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease development. Biomark Med 3:617–53
   PubMed Web of Science ®Google Scholar
• Wiesmann F, Petersen SE, Leeson PM, et al. (2004). Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol 44:2056–64
   PubMed Web of Science ®Google Scholar
• Winkelmann BR, Boehm BO, Nauck M, et al. (2001). Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Curr Med Res Opin 17:132–41
   PubMed Web of Science ®Google Scholar
• Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. (2000). Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol 20:271–9
   PubMed Web of Science ®Google Scholar
• Yoshida O, Kondo T, Kureishi-Bando Y, et al. (2010). Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers. Circ J 74:195–202
   PubMed Web of Science ®Google Scholar
• Yufu K, Takahashi N, Hara M, et al. (2007). Measurement of the brachial-ankle pulse wave velocity and flow-mediated dilatation in young, healthy smokers. Hypertens Res 30:607–12
   PubMedGoogle Scholar
• Yufu K, Takahashi N, Okada N, et al. (2009). Influence of systolic blood pressure and cigarette smoking on endothelial function in young healthy people. Circ J 73:174–8
   PubMed Web of Science ®Google Scholar
• Zeller M, Hatsukami D, Strategic Dialogue on Tobacco Harm Reduction Group. (2009). The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tob Control 18:324–32
   PubMed Web of Science ®Google Scholar